Literature DB >> 6457682

T-lymphocyte subpopulations in chronic lymphocytic leukemia: a quantitative and functional study.

G Semenzato, A Pezzutto, C Agostini, M Albertin, G Gasparotto.   

Abstract

In the peripheral blood of patients with chronic B-cell lymphocytic leukemia (B-CLL) absolute numbers of E-rosetting lymphocytes were increased. The proportions of TG and TM cell subsets were analyzed, as were their effects on the pokeweed mitogen (PWM)-dependent differentiation of normal allogenic B cells or of autologous leukemic cells. The TG lymphocyte subset was further studied for its cytotoxic activity in antibody-dependent cellular cytotoxicity (ADCC). A marked increase both in percentages and in absolute numbers of TG cells was found. TM lymphocytes percentages were normal, but because of the T lymphocytosis occurring in all patients, the absolute numbers of TM were increased. TM and TG subsets showed helper and suppressor activity, respectively, in PWM-induced B-cell differentiation. TG cells displayed effector cell activity in ADCC. The results provide further evidence that T lymphocytes from patients with B-CLL are functionally normal. However, a noticeable increase of the T-cell subset having suppressor and cytotoxic activity in ADCC was observed. This may be the consequence of a normal immune reaction to the leukemic population.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457682     DOI: 10.1002/1097-0142(19811115)48:10<2191::aid-cncr2820481013>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Memory CD8+ T cells protect dendritic cells from CTL killing.

Authors:  Payal B Watchmaker; Julie A Urban; Erik Berk; Yutaro Nakamura; Robbie B Mailliard; Simon C Watkins; S Marieke van Ham; Pawel Kalinski
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

2.  Impaired mitogen responses of the non-leukaemic B cells from patients with chronic lymphocytic leukaemia.

Authors:  A Morgan; J Eaves; J W Mockford; V Malkovska
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  Lymphoproliferative disease of granular lymphocytes in a patient with concomitant hepatitis B virus infection of CD4 lymphocytes.

Authors:  C Agostini; R Zambello; P Pontisso; A Alberti; L Trentin; F Siviero; R Foà; F Pandolfi; G Semenzato
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

4.  Flow cytometric analysis of T-lymphocyte subpopulations in B-cell chronic lymphocytic leukemia: correlation with clinical stage.

Authors:  M L Hautekeete; R F De Bock; D R Van Bockstaele; G C Colpin; Z N Berneman; M E Peetermans
Journal:  Blut       Date:  1987-11

5.  Reduced T lymphocyte colonies in B chronic lymphocytic leukaemia. III. Evidence of a proliferative abnormality of the T helper cell population.

Authors:  R Foa; F Lauria
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

6.  T cell subpopulations in B cell chronic lymphocytic leukaemias.

Authors:  G Semenzato; F Herrmann; K H Mills
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.

Authors:  F Herrmann; G Sieber; Z Chen; B Enders; B Komischke; H Rühl
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

8.  Abnormal T-cell functions in B-cell chronic lymphocytic leukemia do not imply T-lymphocyte involvement in the leukemic process: report of a case with demonstrated "polyclonality" of T lymphocytes.

Authors:  G Lucivero; J T Prchal; A R Lawton; S Antonaci; L Bonomo
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

9.  T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.

Authors:  K F Mangan; G Chikkappa; P C Farley
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

10.  Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity.

Authors:  Yutaro Nakamura; Payal Watchmaker; Julie Urban; Brian Sheridan; Adam Giermasz; Fumihiko Nishimura; Kotaro Sasaki; Rachel Cumberland; Ravikumar Muthuswamy; Robbie B Mailliard; Adriana T Larregina; Louis D Falo; William Gooding; Walter J Storkus; Hideho Okada; Robert L Hendricks; Pawel Kalinski
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.